Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dahl-Chase Pathology Associates is a premier provider of diagnostic pathology and clinical laboratory services based in Bangor, Maine. The company serves a broad network of hospitals, clinics, and physician offices across Northern and Eastern Maine, providing critical diagnostic insights for patient care. Their service portfolio includes surgical pathology, cytopathology, hematopathology, and advanced molecular diagnostics. Dahl-Chase operates a state-of-the-art laboratory facility that utilizes technologies such as flow cytometry and next-generation sequencing. In 2018, the practice was acquired by Aurora Diagnostics, which subsequently became part of the Sonic Healthcare USA network. Despite the acquisition, the group maintains its local clinical leadership and commitment to the regional healthcare community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dahl-Chase Pathology Associates.